GH Research (GHRS) Interest & Investment Income (2021 - 2025)
GH Research (GHRS) recorded quarterly Interest & Investment Income of -$8.6 million in Q3 2025, down 47.71% quarter-over-quarter from -$5.8 million in Q2 2025, and down 211.03% on a YoY basis from $7.8 million in Q3 2024.
GH Research (GHRS) Interest & Investment Income (2021 - 2025) Analysis & Trends
GH Research's Interest & Investment Income history runs 4 years deep, the most recent figure standing at -$8.6 million for Q3 2025.
- In Q3 2025, Interest & Investment Income fell 211.03% year-over-year to -$8.6 million; the TTM figure through Sep 2025 stood at -$8.6 million (down 211.03% YoY), while the FY2025 annual figure was $11.1 million, up 12.71% from the prior year.
- Interest & Investment Income was -$8.6 million for Q3 2025 at GH Research, down from -$5.8 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $7.8 million in Q3 2024 to a low of -$8.6 million in Q3 2025.
- Historically, Interest & Investment Income has averaged -$2.0 million across 4 years, with a median of -$3.2 million in 2023.
- Biggest YoY gain for Interest & Investment Income was 228.29% in 2024; the steepest drop was 279.31% in 2024.
- A 4-year view of Interest & Investment Income shows it stood at $5.9 million in 2021, then plunged by 202.56% to -$6.0 million in 2023, then soared by 228.29% to $7.8 million in 2024, then tumbled by 211.03% to -$8.6 million in 2025.
- The last three Interest & Investment Income figures came in at -$8.6 million (Q3 2025), -$5.8 million (Q2 2025), and -$2.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.62 Mn |
| Jun 30, 2025 | -5.83 Mn |
| Mar 31, 2025 | -2.76 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | -5.23 Mn |
| Mar 31, 2024 | -2.67 Mn |
| Sep 30, 2023 | -6.05 Mn |
| Jun 30, 2023 | -3.61 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2021 | 5.90 Mn |